Literature DB >> 17492247

Cardiovascular diseases and future risk of hip fracture in women.

U Sennerby1, B Farahmand, A Ahlbom, S Ljunghall, K Michaëlsson.   

Abstract

UNLABELLED: We used a population-based case-control study in women and linkage to the Swedish in-patient register to examine if there is an increased risk of hip fracture after a cardiovascular disease. There was a substantially increased risk of hip fracture after a diagnosis of a cardiovascular disease.
INTRODUCTION: Recent data have indicated that cardiovascular diseases (CVDs) might have a relationship to osteoporosis, which may explain the increased risk of mortality after hip fracture. It is uncertain, however, whether there is an increased risk of fracture after any cardiovascular disease and in subgroups of CVDs. The objective of this study was to determine whether there are associations between CVD and future hip fracture risk. Knowledge of the risk pattern would lead to better understanding of common pathologic pathways of osteoporosis and CVD.
METHODS: We conducted a population-based case-control study of 1,327 incident hip fracture cases and 3,170 randomly selected population controls among women 50-81 years old in Sweden. Information on cardiovascular and other diseases before the fracture was obtained by linkage to the Swedish National Inpatient Register. Odds ratios (OR) and 95% confidence intervals (CI) where calculated by unconditional logistic regression.
RESULTS: Before study entry, CVDs were diagnosed more than twice as commonly among fracture cases (25%) as among controls (12%). Also, after adjustment for variables including several chronic diseases, we found a doubled risk of hip fracture after a CVD event (OR 2.38; 95% CI 1.92-2.94). There was a gradient increase in risk of hip fracture with increasing number of hospitalizations for CVD and highest fracture risk occurred the first year after the CVD event. Hypertension, heart failure, and cerebrovascular lesions remained independent risk factors, with 2- to 3-fold increases in odds ratios, even after mutual adjustments for other CVDs.
CONCLUSION: There was a substantially increased risk of hip fracture in women after a diagnosis of a CVD, a finding compatible with the concept of common pathologic pathways for osteoporotic fractures and CVD.

Entities:  

Mesh:

Year:  2007        PMID: 17492247     DOI: 10.1007/s00198-007-0386-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  43 in total

1.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

Review 2.  Bisphosphonates and atherosclerosis: why?

Authors:  M Bevilacqua; L J Dominguez; S Rosini; M Barbagallo
Journal:  Lupus       Date:  2005       Impact factor: 2.911

3.  Oral-contraceptive use and risk of hip fracture: a case-control study.

Authors:  K Michaëlsson; J A Baron; B Y Farahmand; I Persson; S Ljunghall
Journal:  Lancet       Date:  1999-05-01       Impact factor: 79.321

4.  The validity of a diagnosis of heart failure in a hospital discharge register.

Authors:  Erik Ingelsson; Johan Arnlöv; Johan Sundström; Lars Lind
Journal:  Eur J Heart Fail       Date:  2005-08       Impact factor: 15.534

5.  Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.

Authors:  Yoshihiro Sato; Yoshiaki Honda; Jun Iwamoto; Tomohiro Kanoko; Kei Satoh
Journal:  JAMA       Date:  2005-03-02       Impact factor: 56.272

6.  Mortality after osteoporotic fractures.

Authors:  O Johnell; J A Kanis; A Odén; I Sernbo; I Redlund-Johnell; C Petterson; C De Laet; B Jönsson
Journal:  Osteoporos Int       Date:  2003-10-30       Impact factor: 4.507

Review 7.  Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis.

Authors:  Michael W Rajala; Philipp E Scherer
Journal:  Endocrinology       Date:  2003-09       Impact factor: 4.736

Review 8.  Cardiovascular disease and osteoporosis.

Authors:  V Baldini; M Mastropasqua; C M Francucci; E D'Erasmo
Journal:  J Endocrinol Invest       Date:  2005       Impact factor: 4.256

Review 9.  Homocysteine and essential hypertension.

Authors:  Ramón Rodrigo; Walter Passalacqua; Julia Araya; Myriam Orellana; Gonzalo Rivera
Journal:  J Clin Pharmacol       Date:  2003-12       Impact factor: 3.126

10.  Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Ronenn Roubenoff; Charles A Dinarello; Tamara Harris; Emelia J Benjamin; Douglas B Sawyer; Daniel Levy; Peter W F Wilson; Ralph B D'Agostino
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

View more
  49 in total

1.  Association of Paraoxonase 1 (PON1) polymorphisms with osteoporotic fracture risk in postmenopausal Korean women.

Authors:  Beom-Jun Kim; Shin-Yoon Kim; Yoon Shin Cho; Bon-Jo Kim; Bok-Ghee Han; Eui-Kyun Park; Seung Hun Lee; Ha Young Kim; Ghi Su Kim; Jong-Young Lee; Jung-Min Koh
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

2.  Increased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women.

Authors:  R A Mangiafico; C Alagona; P Pennisi; N Parisi; M Mangiafico; F Purrello; C E Fiore
Journal:  Osteoporos Int       Date:  2007-08-04       Impact factor: 4.507

3.  Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study.

Authors:  J Blouin; A Dragomir; M Fredette; L-G Ste-Marie; J C Fernandes; S Perreault
Journal:  Osteoporos Int       Date:  2008-12-24       Impact factor: 4.507

Review 4.  HDL cholesterol and bone mineral density: is there a genetic link?

Authors:  Cheryl L Ackert-Bicknell
Journal:  Bone       Date:  2012-02       Impact factor: 4.398

5.  Osteoporotic fractures and heart failure in the community.

Authors:  Yariv Gerber; L Joseph Melton; Susan A Weston; Véronique L Roger
Journal:  Am J Med       Date:  2011-05       Impact factor: 4.965

Review 6.  Bone Microarchitecture in Type 1 Diabetes: It Is Complicated.

Authors:  Hillary A Keenan; Ernesto Maddaloni
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

7.  Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.

Authors:  C K Choi; S -S Kweon; Y -H Lee; H -S Nam; K -S Park; S -Y Ryu; S -W Choi; S A Kim; M -H Shin
Journal:  Osteoporos Int       Date:  2018-07-16       Impact factor: 4.507

8.  Meta-analysis of hypertension and osteoporotic fracture risk in women and men.

Authors:  C Li; Y Zeng; L Tao; S Liu; Z Ni; Q Huang; Q Wang
Journal:  Osteoporos Int       Date:  2017-04-26       Impact factor: 4.507

9.  Severity of aortic calcification is positively associated with vertebral fracture in older men--a densitometry study in the STRAMBO cohort.

Authors:  P Szulc; E J Samelson; E Sornay-Rendu; R Chapurlat; D P Kiel
Journal:  Osteoporos Int       Date:  2012-08-08       Impact factor: 4.507

10.  Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk.

Authors:  B Abrahamsen; K Brixen
Journal:  Osteoporos Int       Date:  2008-08-09       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.